The Alzheimer's Association is pleased to welcome these distinguished plenary speakers to AAIC 2026.
Sunday, July 12
Ryan Watts, Ph.D.
CEO — Denali Therapeutics, United States
Plenary session title: Accelerating the Discovery and Development of Medicines for Neurodegeneration
Monday, July 13
Suzanne E. Schindler, M.D., Ph.D.
Associate Professor, School of Medicine — Washington University in St. Louis, United States
Plenary session title: Eligibility for Anti-Amyloid Immunotherapy: Amyloid Biomarkers in the Real World
Daisy Acosta, M.D.
Professor — Universidad Nacional Pedro Henriquez Ureña (UNPHU) and Asociación Dominicana de Alzheimer, Dominican Republic
Plenary session title: Understanding Dementia in Latin America: New Insights from the 10/66 Studies
Tuesday, July 14
Takaomi C. Saido, Ph.D.
Professor — RIKEN Center for Brain Science and Keio University School of Medicine, Japan
Plenary session title: From Curiosity to Cure: The Neprilysin-Donanemab and Amyloid Beta-Tau Axes in Alzheimer’s Disease
Betty Tijms, Ph.D.
Head of Science, Alzheimer Center Amsterdam — Amsterdam UMC and Amsterdam Neuroscience, Netherlands
Plenary session title: Proteomic Subtypes of AD: What Do They Mean and How Will They Influence or Benefit Drug Development for Alzheimer's Disease?
Wednesday, July 15
Zahinoor Ismail, M.D.
Professor — University of Calgary, Canada and University of Exeter, United Kingdom
Plenary session title: Neuropsychiatric Manifestations of Alzheimer's Disease and Other Dementia
Dag Aarsland, M.D.
Professor — King's College London, United Kingdom and Stavanger University Hospital, Norway
Plenary session title: Prevalence of Alzheimer’s Disease Pathology in the Community
Advance Your Career
Join ISTAART, an inclusive global network of scientists, clinicians and dementia professionals. With newly discounted rates and free memberships for students, it’s easier than ever to become a part of ISTAART.